24.36
Surgery Partners Inc stock is traded at $24.36, with a volume of 691.66K.
It is down -0.04% in the last 24 hours and down -5.65% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$24.37
Open:
$24.3
24h Volume:
691.66K
Relative Volume:
0.54
Market Cap:
$3.11B
Revenue:
$2.89B
Net Income/Loss:
$-33.80M
P/E Ratio:
-90.22
EPS:
-0.27
Net Cash Flow:
$204.10M
1W Performance:
+4.10%
1M Performance:
-5.65%
6M Performance:
-26.47%
1Y Performance:
-12.06%
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SGRY
Surgery Partners Inc
|
24.36 | 3.11B | 2.89B | -33.80M | 204.10M | -0.27 |
![]()
HCA
Hca Healthcare Inc
|
334.18 | 82.28B | 70.60B | 5.76B | 5.64B | 21.97 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
24.78 | 14.54B | 20.87B | 715.14M | 1.67B | 1.2209 |
![]()
DVA
Davita Inc
|
149.83 | 13.14B | 12.67B | 827.68M | 1.42B | 9.27 |
![]()
THC
Tenet Healthcare Corp
|
127.75 | 12.48B | 20.97B | 3.13B | 2.39B | 31.21 |
![]()
UHS
Universal Health Services Inc
|
178.08 | 11.58B | 15.42B | 1.03B | 956.84M | 15.02 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-16-24 | Initiated | BofA Securities | Buy |
Oct-14-24 | Initiated | UBS | Buy |
Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
Jun-28-24 | Initiated | Macquarie | Outperform |
Mar-06-24 | Initiated | Barclays | Equal Weight |
Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
May-12-23 | Initiated | Mizuho | Buy |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
Jan-10-22 | Resumed | Citigroup | Buy |
Nov-30-21 | Initiated | Barclays | Overweight |
Nov-29-21 | Upgrade | Stifel | Hold → Buy |
Nov-01-21 | Initiated | JP Morgan | Neutral |
Oct-18-21 | Initiated | SVB Leerink | Outperform |
Sep-10-21 | Initiated | Cowen | Market Perform |
Jun-23-21 | Resumed | Stifel | Hold |
Sep-17-20 | Reiterated | The Benchmark Company | Buy |
Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
Jan-14-20 | Reiterated | The Benchmark Company | Buy |
Nov-16-18 | Initiated | UBS | Neutral |
Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
Jun-28-18 | Upgrade | Stifel | Sell → Hold |
Jan-30-18 | Reiterated | The Benchmark Company | Buy |
Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
Aug-09-17 | Downgrade | Stifel | Hold → Sell |
Apr-24-17 | Reiterated | Stifel | Hold |
Mar-10-17 | Downgrade | Stifel | Buy → Hold |
Jan-31-17 | Initiated | The Benchmark Company | Buy |
Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
Oct-27-15 | Initiated | Stifel | Buy |
Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
Ambulatory Surgical Centers Market: Transforming Outpatient - openPR
Surgery Partners Inc (SGRY) Stock Price Down 5.48% on Jan 14 - GuruFocus.com
Surgery Partners’ chief strategy officer Marissa Brittenham sells $76,028 in stock - Investing.com India
U.S. Ambulatory Surgery Center Market Set to Witness Significant Growth by 2025-2032: AmSurg Corp., Surgery - EIN News
Surgery Partners (NASDAQ:SGRY) Price Target Lowered to $33.00 at Macquarie - Defense World
(SGRY) Trading Report - Stock Traders Daily
Macquarie Trims Price Target on Surgery Partners to $33 From $34, Keeps Outperform Rating - Marketscreener.com
Earnings call transcript: Surgery Partners Inc Q4 2024 beats forecasts By Investing.com - Investing.com Australia
Surgery Partners, Inc. SEC 10-K Report - TradingView
Surgery Partners, Inc. to Host Earnings Call - ACCESS Newswire
Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2024 Earnings Call Transcript - MSN
Surgery Partners (SGRY) Q4 Earnings and Revenues Surpass Estimates - MSN
Surgery Partners to Acquire National Surgical Healthcare from Irving Place Capital - Bain Capital
Why Surgery Partners’ Stock Is Facing Turbulence - TipRanks
KeyBanc maintains Sector Weight on Surgery Partners stock By Investing.com - Investing.com Australia
Surgery Partners: Strong Growth and Strategic Positioning Drive Buy Rating - TipRanks
Surgery Partners Delays Annual Report Filing - TipRanks
Surgery Partners stock price target cut to $35 by Benchmark - Investing.com India
UBS cuts Surgery Partners stock target to $34, maintains Buy rating - Investing.com India
KeyBanc maintains Sector Weight on Surgery Partners stock - Investing.com India
UBS cuts Surgery Partners stock target to $34, maintains Buy rating By Investing.com - Investing.com South Africa
UBS Cuts Price Target on Surgery Partners to $34 From $38, Keeps Buy Rating -March 04, 2025 at 08:55 am EST - Marketscreener.com
Surgery Partners price target lowered to $35 from $40 at Benchmark - TipRanks
Surgery Partners Inc (SGRY) Q4 2024 Earnings Call Highlights: Re - GuruFocus.com
Surgery Partners Inc (SGRY) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion - Yahoo Finance
Surgery Partners outlines 2025 guidance with $3.3B-$3.45B revenue target, driven by high acuity growth - MSN
Surgery Partners Reports Strong Revenue Growth for 2024 - TipRanks
Surgery Partners Inc. Reports Record Growth in Earnings Call - TipRanks
Earnings call transcript: Surgery Partners Inc Q4 2024 beats forecasts - Investing.com India
Healthcare Companies Excel In Q1 2024 Earnings Reports - Evrim Ağacı
Surgery Partners Surges on Strong Q4 Results and Bain Capital Pr - GuruFocus.com
Surgery Partners: Q4 Earnings Snapshot - mySA
Surgery Partners Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Surgery Partners Inc (SGRY) Q4 2024 Earnings: Revenue Surpasses Estimates at $864.4 Million, Net Loss Reported - GuruFocus.com
Surgery Partners Surpasses Q4 2024 Revenue Expectations by 4.3%News and Statistics - IndexBox, Inc.
Surgery Partners Inc earnings beat by $0.05, revenue topped estimates - Investing.com Australia
Surgery Partners beats Q4 estimates, shares rise nearly 4% on strong outlook By Investing.com - Investing.com South Africa
Surgery Partners beats Q4 estimates, shares rise nearly 4% on strong outlook - Investing.com Canada
Surgery Partners Sees Increase In Full-year Revenue; Stock RisesUpdate - Nasdaq
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):